Chen, Jin-long

Affiliated Entities

Ngm Biopharmaceuticals, Inc.	Tenaya Therapeutics, Inc.

On PlainSite Chat

No one has posted about Chen, Jin-long yet.

Share something about Chen, Jin-long:

An active PlainSite Pro or Pro Se subscription is required to view the Activity Timeline.

Outside Counsel (2)

	Last Name	First Name	Middle Name	Firm	Location
	Chen	Jinlong
				No. 2, Potangdi Vill., Chendong Vill., Baoxu...	HUAZHOU,

Insider Trading History

SEC Filings

Filter By Form All Records 3 4 From To

	Date	Entity	Form Number	Description	Value
	6/12/2023	Tenaya Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	3/6/2023	Ngm Biopharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	1/18/2023	Ngm Biopharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities	$560.8K
	6/13/2022	Tenaya Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	3/4/2022	Ngm Biopharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	12/7/2021	Ngm Biopharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities	$652.1K
	11/16/2021	Ngm Biopharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities	$591.8K
	10/13/2021	Ngm Biopharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities	$608.3K
	9/14/2021	Ngm Biopharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities	$775.3K
	8/11/2021	Ngm Biopharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities	$714.2K
	7/29/2021	Tenaya Therapeutics, Inc.	3	Initial statement of beneficial ownership of securities
	6/7/2021	Ngm Biopharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities	$100.0K
	5/4/2021	Ngm Biopharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities	$690.5K
	4/13/2021	Ngm Biopharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities	$616.3K
	3/18/2021	Ngm Biopharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	3/2/2021	Ngm Biopharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities	$666.5K
	2/17/2021	Ngm Biopharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities	$718.8K
	1/6/2021	Ngm Biopharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities	$822.1K
	12/16/2020	Ngm Biopharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities	$700.3K
	11/4/2020	Ngm Biopharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities	$442.5K
	10/13/2020	Ngm Biopharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities	$425.5K
	9/3/2020	Ngm Biopharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities	$445.8K
	8/11/2020	Ngm Biopharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities	$475.5K
	7/2/2020	Ngm Biopharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities	$472.7K
	6/17/2020	Ngm Biopharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities	$541.2K
	2/6/2020	Ngm Biopharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	1/9/2020	Ngm Biopharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities	$1.14M
	11/4/2019	Ngm Biopharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities	$875.6K
	4/3/2019	Ngm Biopharmaceuticals, Inc.	3	Initial statement of beneficial ownership of securities

Incoming Payments

This individual has not disclosed any incoming payments from lobbying groups.

Outgoing Payments

This individual has not disclosed any outgoing payments to lobbying groups.

Affiliated Entities

• Ngm Biopharmaceuticals, Inc.
• Tenaya Therapeutics, Inc.